Quinidine Sulfate (Watson Laboratories, Inc.)


Welcome to the PulseAid listing for the Quinidine Sulfate drug offered from Watson Laboratories, Inc.. This Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Watson Laboratories, Inc.
NON-PROPRIETARY NAME: Quinidine Sulfate
SUBSTANCE NAME: QUINIDINE SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1976-11-24
END MARKETING DATE: 0000-00-00


Quinidine Sulfate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionQuinidine Sulfate from Watson Laboratories, Inc.
LABELER NAME: Watson Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 1976-11-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-5438_89d03d0f-7d8c-4f38-a310-9a9739a03397
PRODUCT NDC: 0591-5438
APPLICATION NUMBER: ANDA083288

Other QUINIDINE SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementQuinidine Sulfate
Eon Labs, Inc.Quinidine Sulfate
Watson Laboratories, Inc.Quinidine Sulfate